Researchers at the University of Maryland School of Medicine (UMSOM) have conducted a study that has determined the role that a critical protein plays in the development of hair cells. These hair cells are vital for hearing. Some of these cells amplify sounds that come into the ear, and others transform sound waves into electrical signals that travel to the brain.
Ronna Hertzano, MD, PhD, Associate Professor in the Department of Otorhinolaryngology Head and Neck Surgery at UMSOM andMaggie Matern, PhD, a postdoctoral fellow at Stanford University, demonstrated that the protein, called GFI1, may be critical for determining whether an embryonic hair cell matures into a functional adult hair cell or becomes a different cell that functions more like a nerve cell or neuron.
The study was published in the journalDevelopment, and was conducted by physician-scientists and researchers at theUMSOM Department of Otorhinolaryngology Head and Neck Surgeryand theUMSOM Institute for Genome Sciences (IGS), in collaboration with researchers at the Sackler School of Medicine at Tel Aviv University in Israel.
Hearing relies on the proper functioning of specialized cells within the inner ear called hair cells. When the hair cells do not develop properly or are damaged by environmental stresses like loud noise, it results in a loss of hearing function.
In the United States, the prevalence of hearing loss doubles with every 10-year increase in age, affecting about half of all adults in their 70s and about 80 percent of those who are over age 85. Researchers have been focusing on describing the developmental steps that lead to a functional hair cell, in order to potentially generate new hair cells when old ones are damaged.
To conduct her latest study, Dr. Hertzano and her team utilized cutting-edge methods to study gene expression in the hair cells of genetically modified newborn mice that did not produce GFI1. They demonstrated that, in the absence of this vital protein, embryonic hair cells failed to progress in their development to become fully functional adult cells. In fact, the genes expressed by these cells indicated that they were likely to develop into neuron-like cells.
Our findings explain why GFI1 is critical to enable embryonic cells to progress into functioning adult hair cells, said Dr. Hertzano. These data also explain the importance of GFI1 in experimental protocols to regenerate hair cells from stem cells. These regenerative methods have the potential of being used for patients who have experienced hearing loss due to age or environmental factors like exposure to loud noise.
Dr. Hertzano first became interested in GFI1 while completing her M.D., Ph.D. at Tel Aviv University. As part of her dissertation, she discovered that the hearing loss resulting from mutations in another protein called POU4F3 appeared to largely result from a loss of GFI1 in the hair cells. Since then, she has been conducting studies to discover the role of GFI1 and other proteins in hearing. Other research groups in the field are now testing these proteins to determine whether they can be used as a cocktail to regenerate lost hair cells and restore hearing.
Hearing research has been going through a Renaissance period, not only from advances in genomics and methodology, but also thanks to its uniquely collaborative nature among researchers, said Dr. Herzano.
The new study was funded by the National Institute on Deafness and Other Communication Disorders (NIDCD) which is part of the National Institutes of Health (NIH). It was also funded by the Binational Scientific Foundation (BSF).
This is an exciting new finding that underscores the importance of basic research to lay the foundation for future clinical innovations, saidE. Albert Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine. "Identifying the complex pathways that lead to normal hearing could prove to be the key for reversing hearing loss in millions of Americans."
Reference: Matern MS, Milon B, Lipford EL, et al. GFI1 functions to repress neuronal gene expression in the developing inner ear hair cells. Development. 2020;147(17):dev186015. doi:10.1242/dev.186015.
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.
Read the original:
Proteins Role in Hair Cell Development Is Identified - Technology Networks
- First of its kind stem cell transplant treatment in Boston restores vision to patient - Yahoo - April 8th, 2025
- People are getting costly stem cell injections for knee osteoarthritis, but we don't know if they work - Medical Xpress - April 6th, 2025
- Say goodbye to joint pain without surgery: Expert shares 8 tips on diet plan, lifestyle tweaks, treatments and therapies - Hindustan Times - April 6th, 2025
- Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan -... - April 6th, 2025
- Revolutionizing Success in the Cell Therapy Regenerative - openPR.com - April 4th, 2025
- 5 Best Stem Cell Companies to Invest In (April 2025) - Securities.io - April 4th, 2025
- Boys with cancer can face infertility as adults. Can storing their stem cells help? - Ravalli Republic - April 4th, 2025
- Tip Sheet: Nutrition for People Receiving Stem Cell Transplants, Art Therapy for Cancer Patients, Treating a Rare Type of Colon Cancer and Graduate... - April 4th, 2025
- Human Organoid Market is Set to Revolutionize Drug Discovery and Disease Modeling - openPR.com - April 1st, 2025
- Doctors Told Him He Was Going to Die. Then A.I. Saved His Life. - The New York Times - March 24th, 2025
- Japan team says stem cell treatment helped improve spinal cord injuries | NHK WORLD-JAPAN News - NHK WORLD - March 22nd, 2025
- Boost in cancer treatment: PGI working on lab for stem cell, gene therapies - The Times of India - March 19th, 2025
- Stem Cell Stocks on the Rise: Companies Driving the $48 Billion Market Boom - openPR - March 19th, 2025
- Neuroregeneration Therapy Market Forecasted to Expand at 5.3% CAGR, Reaching USD 64.8 Billion by 2034 - Transparency Market Research, Inc -... - March 19th, 2025
- Cell Therapy Market Surges as Breakthrough Innovations Transform Regenerative Medicine - openPR - March 17th, 2025
- Infinite Health Integrative Medicine Center Fights Chronic Pain with Stem Cell Prolotherapy - PR Newswire - March 14th, 2025
- Stem Cell and Exosome Innovations at Infinite Health Integrative Medicine Center Offers New Hope for Parkinson's Disease - PR Newswire - March 14th, 2025
- Adia Nutrition Hunts for Top Sales Talent to Power Adia Med and Adia Labs Expansion - TradingView - March 14th, 2025
- Cell Therapy Market Poised for Exponential Growth, Projected to Reach USD 44.6 Billion by 2034 - openPR - March 14th, 2025
- Trial Repairs Irreversible Corneal Damage With Stem Cell Therapy - Anti Aging News - March 11th, 2025
- Advancing Regenerative Medicine: A Comprehensive Outlook on the Global Cell Therapy Market - openPR - March 7th, 2025
- Top 3 Grants in Regenerative Medicine: February 2025 - RegMedNet - March 7th, 2025
- The future of cell therapy: scaling production for global reach - Drug Target Review - March 7th, 2025
- Stem Cell Therapy Repairs Corneal Damage in Trial - Mirage News - March 7th, 2025
- Autologous Cell Therapy Market Anticipated to Hit USD 12.1 Billion by 2031: Persistence Market Research Study - openPR - March 7th, 2025
- Regenerative Therapies Market Forecast to Reach USD 24.41 Billion by 2033 - Persistence Market Research - openPR - March 5th, 2025
- This Japanese Regenerative Medicine Company Just Secured Its Path to NASDAQ Through a $242M Deal - StockTitan - March 5th, 2025
- Ryoncil, the first FDA-approved mesenchymal stromal cell therapy - Yahoo - March 5th, 2025
- Animal Stem Cell Therapy Market Forecast to Reach USD 437.3 - openPR - March 3rd, 2025
- A Navy SEALs Journey to Stem Cell Treatment: The Future of Medicine is Here, Just Not in America - SOFREP - March 3rd, 2025
- InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug - Forbes - March 3rd, 2025
- VUMC Part of New Study Validating Curative Therapy for Sickle Cell Disease A - Wgnsradio - March 1st, 2025
- Advancing Stem Cell Therapy and Equity in Patient Care - Targeted Oncology - February 27th, 2025
- How Stem Cell Treatment Reversed A Pro Athlete's Life-threatening Long COVID Disease When all Other treatment Failed - Medical Tourism Magazine - February 27th, 2025
- Allogeneic Cell Therapy Market Size to Hit USD 4,677.38 Million by 203 - BioSpace - February 27th, 2025
- Bringing Fibroblasts to the Spotlight: Q&A with FibroBiologics - Pharmaceutical Executive - February 27th, 2025
- Mount Sinai-Led Research Team Identifies Underlying Mechanisms of Age-Related Dysfunction in Glands Crucial to Eye Function | Newswise - Newswise - February 25th, 2025
- Experts explore the future of iPSC-based cell therapies - Drug Target Review - February 19th, 2025
- Longeveron Announces World Health Organization Approval of laromestrocel as International Non-proprietary Name for Stem Cell Therapy Lomecel-B -... - February 19th, 2025
- The impact of cytokines on stem cells and organoid research in drug discovery - News-Medical.Net - February 19th, 2025
- Revolutionary FDA-Approved Stem Cell Partnership Puts Adia Med at Forefront of Regenerative Medicine - StockTitan - February 19th, 2025
- Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US - BioSpace - February 19th, 2025
- Bahrain's pioneering use of sickle cell disease treatment hailed by medical experts - The National - February 19th, 2025
- Uganda Treats First Patient Using Stem Cell Therapy - AllAfrica - Top Africa News - February 19th, 2025
- Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US - StreetInsider.com - February 17th, 2025
- Diversity of Cells Allow Colon Cancer to Resist Treatment and To Metastasize - MedicalResearch.com - February 15th, 2025
- Survival outcomes between haploidentical stem cell transplantation and chemotherapy for blastic plasmacytoid dendritic cell neoplasm - Nature.com - February 13th, 2025
- Experimental cell therapy trial treats first Sjgrens disease patient - University of Wisconsin School of Medicine and Public Health - February 11th, 2025
- Stem Cell Therapy Market Types, Applications, Share, Growth - openPR - February 6th, 2025
- Placental Stem Cell Therapy Solution Market Size And Booming - openPR - February 6th, 2025
- Revitalizing Health with Stem Cell Therapy: A Groundbreaking Path To Longevity and Wellness - openPR - February 4th, 2025
- Gene therapy offers new hope for sickle cell disease patients - Open Access Government - February 4th, 2025
- Scientists trial implant to patch up the heart - BBC.com - February 2nd, 2025
- Cell Therapy Market Size is Projected to Reach USD 33.93 - GlobeNewswire - January 28th, 2025
- Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3 - The Medicine Maker - January 28th, 2025
- Immusoft to Present Positive Data from the First Engineered B Cell in a Human Clinical Trial at the 21st Annual WorldSymposium 2025 - The Eastern... - January 28th, 2025
- Beyond the Lab: Stem cell research - Drug Target Review - January 25th, 2025
- Asia Pacific Stem Cell Therapy Market to Reach US$ 4,075.75 Million by 2033 with a Robust CAGR of 10.29% - openPR - January 25th, 2025
- Exciting data: S.Biomedics preps US IND of PD cell therapy - BioWorld Online - January 25th, 2025
- $24.85 Billion Cell Therapy Market Forecast by 2032 (CAGR 20.4%) - openPR - January 25th, 2025
- Stem Cell Therapy Market Expected to Expand at a Steady 2025-2032 - openPR - January 25th, 2025
- Regenerative Medicine Market to receive overwhelming hike US$ 164.9 billion in Revenues by 2032, Growing at a CAGR of 23.30% From 2024 to 2032 -... - January 25th, 2025
- Alternative medicine fans see RFK Jr. as a hero. The fields skeptics worry. - The Washington Post - January 23rd, 2025
- U.S. PRP and Stem Cell Alopecia Treatment Market Analysis 2025-2030 by Treatment, Indication, and End-use - Androgenic Alopecia Dominated the Market... - January 23rd, 2025
- The Future of Regenerative Medicine Lies in the Hands of Chiropractors - Dynamic Chiropractic - January 23rd, 2025
- Stem Cell Therapy Industry Dynamics and Contributions by RTI - openPR - January 21st, 2025
- Stem Cells Market to Reach USD 44.27 Billion by 2033, Driven by Expanding Applications and Innovations - openPR - January 21st, 2025
- Organoids at the Forefront Innovations in Stem Cell Research and Precision Medicine - openPR - January 21st, 2025
- The promising future of regenerative medicine - Yahoo Finance - January 17th, 2025
- An earful of gill: USC Stem Cell study points to the evolutionary origin of the mammalian outer ear - EurekAlert - January 11th, 2025
- Aspen Partners with Mytos to Automate Stem Cell Production for Parkinsons Therapy - Genetic Engineering & Biotechnology News - January 9th, 2025
- School of Medicine professor receives grant to study improved cancer treatments - Mercer University - January 9th, 2025
- Meet CIRM: the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1 - The Medicine Maker - January 7th, 2025
- Regenerative Medicine Market to Experience Significant Growth, Projected to Reach $183.08 Billion by 2031. - openPR - January 7th, 2025
- Stem-cell therapies that work: 10 Breakthrough Technologies 2025 - MIT Technology Review - January 5th, 2025
- 1st stem cell therapy, new HIV drug approved - ecns - January 5th, 2025
- Science fiction turned reality? Stem cell therapy set to repair child's heart - Ynetnews - January 3rd, 2025
- Stem Health Plus Revolutionizes Skin Regeneration with Advanced Stem Cell Skin Graft Technology - The Manila Times - January 1st, 2025
- Allogeneic Stem Cell Transplantation Market Size to Expand Lucratively by 2031 - openPR - January 1st, 2025
- Apoptotic clearance by stem cells: molecular mechanisms for recognition and phagocytosis of dead cells - Nature.com - December 30th, 2024
Recent Comments